MedPath

Evaluation of the effects of herbal medicine on improve diabetic patients

Phase 2
Conditions
Type 2 diabetes mellitus.
Type 2 diabetes mellitus
Registration Number
IRCT20220207053960N1
Lead Sponsor
Fasa University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
80
Inclusion Criteria

Confirmation of type 2 diabetes according to ADA criteria
Age from 40 to 60 years
Having informed consent to participate in the study

Exclusion Criteria

Pregnancy and lactation
History of allergies to herbal products
Disagreement of the responsible physician of the patient before randomization

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
HBA1C. Timepoint: Zero days and 60 days after the start of the intervention. Method of measurement: Spectrophotometry.;FBS. Timepoint: Zero days and 60 days after the start of the intervention. Method of measurement: Auto analyzer.;Lipid profile. Timepoint: Zero days and 60 days after the start of the intervention. Method of measurement: Auto analyzer.;Liver enzymes. Timepoint: Zero days and 60 days after the start of the intervention. Method of measurement: Auto analyzer.;Kidney indicators. Timepoint: Zero days and 60 days after the start of the intervention. Method of measurement: Auto analyzer.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath